Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Max Goodson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Pediatric Endocrinology Reviews : PER|April 28, 2016
Salivary Biomarkers in Pediatric Metabolic Disease ResearchMor-Li Hartman, J Max Goodson, Roula Barake, et al.
Anesthesia Progress|June 13, 2008
Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylatePaul A Moore, Elliot V Hersh, Athena S Papas, et al.
Journal of the American Dental Association (1939)|August 7, 2008
Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adultsElliot V Hersh, Paul A Moore, Athena S Papas, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 8, 2015
Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese childrenMor-Li Hartman, J Max Goodson, Roula Barake, et al.
Journal of the American Dental Association (1939)|August 7, 2008
Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patientsMary Tavares, J Max Goodson, Deborah Studen-Pavlovich, et al.
Contributions to Nephrology|May 9, 2013
Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity?Mor-Li Hartman, Francisco Groppo, Mutsuko Ohnishi, et al.
Journal of Clinical Periodontology|April 20, 2012
Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sitesJ Max Goodson, Anne D Haffajee, Sigmund S Socransky, et al.
Journal of the American Dental Association (1939)|November 4, 2006
The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: two controlled clinical trialsPaul A Moore, Sean G Boynes, Elliot V Hersh, et al.
Plos One|October 17, 2013
Obesity and dental decay: inference on the role of dietary sugarJ Max Goodson, Mary Tavares, Xiaoshan Wang, et al.
Journal of Periodontology|February 6, 2007
Hemostatic and anesthetic efficacy of 4% articaine HCl with 1:200,000 epinephrine and 4% articaine HCl with 1:100,000 epinephrine when administered intraorally for periodontal surgeryPaul A Moore, Bruce Doll, Robert A Delie, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Pediatric Endocrinology Reviews : PER|April 28, 2016
Salivary Biomarkers in Pediatric Metabolic Disease ResearchMor-Li Hartman, J Max Goodson, Roula Barake, et al.
Anesthesia Progress|June 13, 2008
Pharmacokinetics of lidocaine with epinephrine following local anesthesia reversal with phentolamine mesylatePaul A Moore, Elliot V Hersh, Athena S Papas, et al.
Journal of the American Dental Association (1939)|August 7, 2008
Reversal of soft-tissue local anesthesia with phentolamine mesylate in adolescents and adultsElliot V Hersh, Paul A Moore, Athena S Papas, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 8, 2015
Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese childrenMor-Li Hartman, J Max Goodson, Roula Barake, et al.
Journal of the American Dental Association (1939)|August 7, 2008
Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patientsMary Tavares, J Max Goodson, Deborah Studen-Pavlovich, et al.
Contributions to Nephrology|May 9, 2013
Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity?Mor-Li Hartman, Francisco Groppo, Mutsuko Ohnishi, et al.
Journal of Clinical Periodontology|April 20, 2012
Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sitesJ Max Goodson, Anne D Haffajee, Sigmund S Socransky, et al.
Journal of the American Dental Association (1939)|November 4, 2006
The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: two controlled clinical trialsPaul A Moore, Sean G Boynes, Elliot V Hersh, et al.
Plos One|October 17, 2013
Obesity and dental decay: inference on the role of dietary sugarJ Max Goodson, Mary Tavares, Xiaoshan Wang, et al.
Journal of Periodontology|February 6, 2007
Hemostatic and anesthetic efficacy of 4% articaine HCl with 1:200,000 epinephrine and 4% articaine HCl with 1:100,000 epinephrine when administered intraorally for periodontal surgeryPaul A Moore, Bruce Doll, Robert A Delie, et al.
Pageof 5